<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Bull Math Biol</journal-id><journal-id journal-id-type="pmc-domain-id">365</journal-id><journal-id journal-id-type="pmc-domain">springeropen</journal-id><journal-title-group><journal-title xml:lang="en">Bulletin of Mathematical Biology</journal-title></journal-title-group><issn pub-type="ppub">0092-8240</issn><issn pub-type="epub">1522-9602</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>Springer</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC2799010</article-id><article-id pub-id-type="pmcid-ver">PMC2799010.1</article-id><article-id pub-id-type="pmcaid">2799010</article-id><article-id pub-id-type="pmcaiid">2799010</article-id><article-id pub-id-type="pmid">17024551</article-id><article-id pub-id-type="doi">10.1007/s11538-006-9122-8</article-id><article-id pub-id-type="publisher-id">9122</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Paper</subject></subj-group></article-categories><title-group><article-title>Application of the Convection&#8211;Dispersion Equation to Modelling Oral Drug Absorption</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Freijer</surname><given-names initials="JI">Jan I.</given-names></name><address><email>jan.freijer@nl.astellas.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Post</surname><given-names initials="TM">Teun M.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Ploeger</surname><given-names initials="BA">Bart A.</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>DeJongh</surname><given-names initials="J">Joost</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Danhof</surname><given-names initials="M">Meindert</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label>LAP &amp; P Consultants BV, Archimedesweg 31, 2333 CM Leiden, The Netherlands </aff><aff id="Aff2"><label>2</label>LACDR, Division of Pharmacology, Leiden University, P.O. Box 9502, 2300 RA Leiden, The Netherlands </aff></contrib-group><pub-date pub-type="epub"><day>6</day><month>10</month><year>2006</year></pub-date><pub-date pub-type="ppub"><month>1</month><year>2007</year></pub-date><volume>69</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">183762</issue-id><fpage>181</fpage><lpage>195</lpage><history><date date-type="received"><day>16</day><month>3</month><year>2005</year></date><date date-type="accepted"><day>27</day><month>1</month><year>2006</year></date></history><pub-history><event event-type="pmc-release"><date><day>06</day><month>10</month><year>2006</year></date></event><event event-type="pmc-live"><date><day>15</day><month>01</month><year>2010</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2014-10-27 17:50:49.157"><day>27</day><month>10</month><year>2014</year></date></event></pub-history><permissions><copyright-statement>&#169; Society for Mathematical Biology 2006</copyright-statement></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="11538_2006_Article_9122.pdf"/><abstract xml:lang="en"><p>Models of systemic drug absorption after oral administration are frequently based on a direct or a delayed first-order rate process. In practice, the use of the first-order approach to predict drug concentrations in blood plasma frequently yields a considerable mismatch between predicted and measured concentration profiles. This is particularly true for the upswing of the plasma concentration after oral administration. The current investigation explores an alternative model to describe the absorption rate based on the convection&#8211;dispersion equation describing the transport of chemicals through the GI tract. This equation is governed by two parameters, transport velocity and dispersion coefficient. One solution of this equation for a specific set of initial and boundary conditions was used to model absorption of paracetamol in a 22-year-old man after oral administration. The GI-tract passage rate in this subject was influenced by co-administration of drugs that stimulate or delay gastric emptying. The transport-limited absorption function is more accurate in describing the plasma concentration versus time curve after oral administration than the first-order model. Additionally, it provides a mechanistic explanation for the observed curve through the differences in GI-tract passage rate.</p></abstract><kwd-group><title>Keywords</title><kwd>NONMEM</kwd><kwd>Pharmacokinetics</kwd><kwd>Inverse Gaussian distribution</kwd><kwd>Paracetamol</kwd><kwd>Gastric emptying</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Science+Business Media, Inc. 2007</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>1. Introduction</title><p>Absorption of orally administered drugs from the GI tract is an important determinant of the onset of the drug effect. Not surprisingly, the function describing absorption is a key component of a pharmacokinetic (PK) model. Models of systemic drug absorption are frequently based on a first-order rate process. Closed form solutions have been derived for the simultaneous differential equations describing first-order absorption and one and two compartmental disposition (<xref ref-type="bibr" rid="CR19">Shargel and Yu, 1999</xref>; <xref ref-type="bibr" rid="CR7">Gabrielson and Weiner, 2000</xref>). The first-order absorption model assumes instantaneous presence of the drug in the gut compartment and subsequently an exponential decrease of the absorption rate with time as dictated by the absorption rate constant, <italic>K</italic><sub>a</sub>. The introduction of a lag time between oral administration and the onset of absorption accounts for delays due to passage through the GI tract. A limitation of this model is that it predicts an unrealistically sharp entrance front of the drug at the site of absorption.</p><p>In practice, the use of the first-order approach to predict plasma concentrations frequently yields a mismatch between predicted and measured plasma concentration versus time profiles (<xref ref-type="bibr" rid="CR22">Weiss, 1996</xref>; <xref ref-type="bibr" rid="CR8">Higaki et al., 2001</xref>; <xref ref-type="bibr" rid="CR17">Ring, 2001</xref>). The first-order absorption model cannot describe sigmoid shapes in the upswing of the plasma concentration-time curve. This is related to its exponential decrease of the absorption rate with time, not allowing the presence of an inflection point (See Fig. <xref rid="Fig1" ref-type="fig">1</xref>, left panel). Fitting PK models with first-order absorption to data may thus hamper a sound interpretation of estimated absorption and disposition parameters. Various alternatives have been discussed for the first-order absorption model. A very extensive overview of different strategies to characterise drug absorption profiles is provided by <xref ref-type="bibr" rid="CR24">Zhou (2003)</xref>, discussing an array of different absorption models. One of these models is the Weibull distribution, which was suggested by <xref ref-type="bibr" rid="CR15">Piotrovskii (1987)</xref> as an empirical absorption kinetics model in order to improve the description of the concentration-time curve. Recently, <xref ref-type="bibr" rid="CR8">Higaki et al. (2001)</xref> developed a set of six different time-dependent absorption models as alternatives for the conventional first-order absorption model. These models, which include a time dependency in the absorption rate constant, are superior to the conventional first-order model with a lag time in predicting plasma concentration curves. However, all of the proposed models contain at least one additional parameter than the two parameters needed in the first-order absorption model.
<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>Shape of the absorption rate-time relationship and the corresponding concentration-time curve in a 1-compartment model for (1) the first-order absorption model and (2) the inverse Gaussian density function.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO1" position="float" orientation="portrait" xlink:href="11538_2006_Article_9122_Fig1.jpg"/></fig></p><p><xref ref-type="bibr" rid="CR22">Weiss (1996)</xref> has proposed to use the Inverse Gaussian Density (IG)-input function as an alternative to the first-order absorption model to describe the absorption-time curve. Modelling exercises have shown that this type of absorption model can adequately describe an inflection point (Fig. <xref rid="Fig1" ref-type="fig">1</xref>, right panel) in the concentration-time curve when combined with a 1-compartment pharmacokinetic model (<xref ref-type="bibr" rid="CR22">Weiss, 1996</xref>; <xref ref-type="bibr" rid="CR23">Weiss et al., 1997</xref>; <xref ref-type="bibr" rid="CR17">Ring, 2001</xref>). The appealing aspect of this input function is that it contains just two parameters. These parameters have a clear meaning in terms of the progress of the absorption process.</p><p>A possible mechanism that can explain the IG shape of the absorption-time curve is convective-dispersive transport from the site of administration to the gut. The drug has to pass the oesophagus, the stomach, and the duodenum, before arriving in the gut, which modulates the original input pulse. It is the purpose of this paper to clarify the theoretical background and rationale of the convective- dispersive transport equations in calculating absorption profiles. The application of the absorption model is illustrated by an example from the literature (<xref ref-type="bibr" rid="CR13">Nimmo et al., 1973</xref>).</p></sec><sec id="Sec2"><title>2. Theory</title><sec id="Sec3"><title>2.1. Mass balance</title><p>In pharmacokinetic models the mass balance at the absorption site, i.e. the gut compartment, is considered as the result of an incoming transport flux, <italic>N</italic><sub>in</sub>, loss via excretion, <italic>N</italic><sub>out</sub>, and loss via absorption, <italic>N</italic><sub>abs</sub>:
<disp-formula id="Equ1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$${{{\rm{d}}{A_G}} \over {{\rm{d}}t}} = {N_{{\rm&lt;Subscript&gt;&lt;/Subscript&gt;}}}(t) - {N_{{\rm{out}}}}(t) - {N_{{\rm{abs}}}}(t)$$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu1.gif"/></alternatives></disp-formula> where <italic>A</italic><sub>G</sub> is the amount of delivered drug at the site of absorption. The above mass balance equation thus considers a point mass balance at the absorption site, without specifying the local conditions that determine the terms on the right-hand side of the equation. A common assumption is that a constant fraction is unavailable for absorption and is consequently excreted:
<disp-formula id="Equ2"><alternatives><tex-math id="M2">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$${N_{{\rm{out}}}} = (1 - F){N_{{\rm&lt;Subscript&gt;&lt;/Subscript&gt;}}}$$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu2.gif"/></alternatives></disp-formula> where <italic>F</italic> is the bioavailability fraction. Assuming first-order absorption, this leads to the following equation (<xref ref-type="bibr" rid="CR19">Shargel and Yu, 1999</xref>):
<disp-formula id="Equ3"><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$${{d{A_G}} \over {{\rm{d}}t}} = F{N_{{\rm&lt;Subscript&gt;&lt;/Subscript&gt;}}}(t) - {K_a}{A_{\rm{G}}}$$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu3.gif"/></alternatives></disp-formula> where <italic>K</italic><sub>a</sub> is a rate constant, and <italic>N</italic><sub>in</sub>(<italic>t</italic>) is considered as a series of instantaneous pulses, representing the dosages. Alternatively, it can be assumed that the absorption rate is not the limiting factor, but transport to the gut (<italic>N</italic><sub>in</sub>), which leads to the following approximate equation:
<disp-formula id="Equ4"><alternatives><tex-math id="M4">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$${N_{{\rm{abs}}}} = F{N_{{\rm&lt;Subscript&gt;&lt;/Subscript&gt;}}}$$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu4.gif"/></alternatives></disp-formula>.</p><p>In order to model the absorption process according to Eq. (<xref rid="Equ4" ref-type="">4</xref>), the transport term <italic>N</italic><sub>in</sub> needs to be described as a function of time.</p><p>The theory for transport of tracer compounds, such as drugs, in bulk fluids that move along a transport direction to a certain site is based on two physical concepts:
<list list-type="order"><list-item><p>The concept of mass balance of drug along the one-dimensional transport axis:
<disp-formula id="Equ5"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$$\eqalign{ &amp; {N_{{\rm{abs}}}} = F{N_{{\rm&lt;Subscript&gt;&lt;/Subscript&gt;}}} \cr &amp; {{\partial C} \over {\partial t}} = - {{\partial J} \over {\partial z}} \cr} $$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu5.gif"/></alternatives></disp-formula> where <italic>C</italic> is concentration, <italic>J</italic> is the mass flux, <italic>t</italic> is time and <italic>z</italic> is transport distance. whereby both <italic>C</italic> and <italic>J</italic> may vary with time and distance.</p></list-item><list-item><p>The assumption of a convective and a dispersive transport term to express the mass flux along the transport direction:
<disp-formula id="Equ6"><alternatives><tex-math id="M6">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$$J = vC - D{{\partial C} \over {\partial z}}$$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu6.gif"/></alternatives></disp-formula> with the mass exchange rate, <italic>N</italic><disp-formula id="Equ7"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$$N = \alpha J$$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu7.gif"/></alternatives></disp-formula> where <italic>v</italic> is the transport velocity and <italic>D</italic> is the dispersion coefficient and &#945; is the cross-sectional area of the flow field, i.e. the mean cross-sectional area of the GI tract. The convective term, <italic>vC</italic>, expresses the transport of drug with the movement of food and liquid suspensions through the GI tract to the gut. The dispersive term, <italic>D&#8706;C/&#8706;z</italic>, accounts for the dispersion in the transport pulse. The dispersion coefficient joins together variations in velocity and tortuous transport path within the GI tract, i.e. the flow lines are assumed to diverge and rejoin.</p></list-item></list></p><p>If no drug is eliminated during transport and if the dispersion coefficient and the transport velocity are adopted as constants, combination of Eqs. (<xref rid="Equ5" ref-type="">5</xref>) and (<xref rid="Equ6" ref-type="">6</xref>) yields:
<disp-formula id="Equ8"><alternatives><tex-math id="M8">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$${{\partial C} \over {\partial t}} = D{{{\partial^2}C} \over {\partial {z^2}}} - v{{\partial C} \over {\partial z}}$$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu8.gif"/></alternatives></disp-formula> which is known as the convection-dispersion equation (<xref ref-type="bibr" rid="CR4">Carslaw and Jaeger, 1959</xref>; <xref ref-type="bibr" rid="CR10">Kreft and Zuber, 1978</xref>). The above partial differential equation can be used to model the transport of drugs to the absorption site, by finding an expression for the flux, <italic>J</italic>, as a function of time at a certain distance from the entrance point (Eqs. (<xref rid="Equ6" ref-type="">6</xref>) and (<xref rid="Equ7" ref-type="">7</xref>)).</p></sec><sec id="Sec4"><title>2.2. Initial and boundary conditions</title><p>To obtain the expression that gives the mass flux as a function of time and distance, Eq. (<xref rid="Equ8" ref-type="">8</xref>) must be solved for the appropriate initial and boundary conditions.</p><p>If no drugs are present in the GI tract, the valid initial condition is:
<disp-formula id="Equ9"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$$C = 0,{\rm{ }}t = 0,{\rm{ }}z &gt; 0$$ 
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu9.gif"/></alternatives></disp-formula> When drugs are taken orally in the form of soluble tablets or a solution, this can be considered as an instantaneous injection into the GI tract. Therefore, the following upper-boundary condition is pertinent:
<disp-formula id="Equ10"><alternatives><tex-math id="M10">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$$C - {D \over v}{{\partial C} \over {\partial z}} = {{{A_{\rm{D}}}} \over {v\alpha }}\delta (t),{\rm{ }}t \ge 0,{\rm{ }}z = 0$$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu10.gif"/></alternatives></disp-formula> where <italic>A</italic><sub>D</sub> is the dose and &#948;(<italic>t</italic>) is the Dirac delta distribution. Eq. (<xref rid="Equ10" ref-type="">10</xref>) incorporates continuity of flux at the upper boundary. This requirement for the mass balance in organs has been discussed previously in the case of liver distribution kinetics (<xref ref-type="bibr" rid="CR9">Hisaka and Sugiyama, 1999</xref>; <xref ref-type="bibr" rid="CR18">Roberts et al., 2000</xref>).</p><p>The lower-boundary condition concerns an assumption about the concentration and/or the concentration gradient at the outlet. The mass balance discussed in Eqs. (<xref rid="Equ1" ref-type="">1</xref>)&#8211;(<xref rid="Equ4" ref-type="">4</xref>) is of little use in formulating the lower-boundary conditions, since it represents a total mass balance without specifying the local condition needed to solve Eq. (<xref rid="Equ8" ref-type="">8</xref>). The nature of the lower-boundary condition has been discussed in some detail (<xref ref-type="bibr" rid="CR14">Parlange et al., 1992</xref>; <xref ref-type="bibr" rid="CR6">Freijer et al., 1998</xref>; <xref ref-type="bibr" rid="CR9">Hisaka and Sugiyama, 1999</xref>; <xref ref-type="bibr" rid="CR18">Roberts et al., 2000</xref>). In the derivation of the IG-input function it is assumed that there is a negligible change of dispersion (mixing) when the food/liquid suspension leaves the duodenum and enters the gut, and the following lower-boundary condition is pertinent:
<disp-formula id="Equ11"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$$\eqalign{ &amp; {{\partial C} \over {\partial z}} = 0,{\rm{ }}t \ge 0,{\rm{ }}z = \infty \cr &amp; \cr} $$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu11.gif"/></alternatives></disp-formula></p></sec><sec id="Sec5"><title>2.3. Solution</title><p>The solution of differential equation (Eq. (<xref rid="Equ8" ref-type="">8</xref>)) with the initial condition (Eq. (<xref rid="Equ9" ref-type="">9</xref>)) and the boundary conditions (Eqs. (<xref rid="Equ10" ref-type="">10</xref>) and (<xref rid="Equ11" ref-type="">11</xref>)) is provided in <xref ref-type="bibr" rid="CR10">Kreft and Zuber (1978)</xref>. The following relationships and definitions are used:
<disp-formula id="Equ12"><alternatives><tex-math id="M12">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$$\eqalign{ &amp; {{\partial C} \over {\partial z}} = 0,{\rm{ }}t \ge 0,{\rm{ }}z = \infty \cr &amp; {C_{\rm{F}}} = C - {D \over v}{{\partial C} \over {\partial z}} \cr} $$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu12.gif"/></alternatives></disp-formula> where <italic>C</italic><sub>F</sub> the &#8220;flux-averaged&#8221; concentration, which relates to <italic>J</italic> by
<disp-formula id="Equ13"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$$J = v{C_{\scriptstyle {\rm{F}} \hfill \atop \scriptstyle \hfill} }$$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu13.gif"/></alternatives></disp-formula> The following dimensionless variables are used:
<disp-formula id="Equ14"><alternatives><tex-math id="M14">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$$\xi = vz/D$$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu14.gif"/></alternatives></disp-formula><disp-formula id="Equ15"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$$\tau = {v^2}t/D$$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu15.gif"/></alternatives></disp-formula> where &#950; and &#964; are dimensionless distance and time, respectively.</p><p>Then, the solution for the concentration is (<xref ref-type="bibr" rid="CR10">Kreft and Zuber, 1978</xref>; <xref ref-type="bibr" rid="CR21">Veling, 1993</xref>):
<disp-formula id="Equ16"><alternatives><tex-math id="M16">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$$C = {{{A_{\rm{D}}}{v^2}} \over {{v_\alpha }D}}\left( {{1 \over {\sqrt {\pi \tau } }}\exp \left( { - {{{{\left( {\zeta - \tau } \right)}^2}} \over {4\tau }}} \right) - {1 \over 2}\exp \left( \zeta \right){\rm{erfc }}\left( {{{\zeta + \tau } \over {2\sqrt \tau }}} \right)} \right)$$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu16.gif"/></alternatives></disp-formula> where the complementary error function is defined as:
<disp-formula id="Equ17"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$${\rm{erfc}}(x) = {2 \over {\sqrt \pi }}\int\limits_x^\infty {\exp ( - {u^2}){\rm{d}}u} $$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu17.gif"/></alternatives></disp-formula>.</p><p>See for an overview of approximations of the complementary error function <xref ref-type="bibr" rid="CR1">Abramowitz and Stegun (1966)</xref>. The solution for the flux-averaged concentration is (<xref ref-type="bibr" rid="CR10">Kreft and Zuber, 1978</xref>; <xref ref-type="bibr" rid="CR21">Veling, 1993</xref>)
<disp-formula id="Equ18"><alternatives><tex-math id="M18">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$${C_{\rm{F}}} = {{{A_{\rm{D}}}{v^2}} \over {v\alpha D}}\left( {{1 \over {2\sqrt \pi }}{{\left[ {{1 \over \tau }} \right]}^{3/2}}\zeta \exp \left( { - {{{{(\xi - \tau )}^2}} \over {4\tau }}} \right)} \right)$$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu18.gif"/></alternatives></disp-formula>.</p><p>Equation (<xref rid="Equ18" ref-type="">18</xref>) is used to express the absorption rate, and not Eq. (<xref rid="Equ16" ref-type="">16</xref>), as the latter expresses the resident concentration, and omits the concentration gradient required to calculate the total (convective and dispersive) flux (<xref ref-type="bibr" rid="CR9">Hisaka and Sugiyama, 1999</xref>; <xref ref-type="bibr" rid="CR18">Roberts et al., 2000</xref>).</p><p>Additionally, the following integral, giving the total mass that has passed distance <italic>z</italic> at time <italic>t</italic> is of interest (<xref ref-type="bibr" rid="CR21">Veling, 1993</xref>):
<disp-formula id="Equ19"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$$M = \alpha \int\limits_z^\infty {C{\rm{d}}u = {A_{\rm{D}}}\left( {{1 \over 2}{\rm{erfc}}\left( {{{\left( {\xi - \tau } \right)} \over {\sqrt {4\tau } }}} \right) + {1 \over 2}\exp (\zeta ){\rm{erfc}}\left( {{{\zeta + \tau } \over {2\sqrt \tau }}} \right)} \right)} $$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu19.gif"/></alternatives></disp-formula>.</p><p>Methods to arrive at these solutions are extensively discussed in <xref ref-type="bibr" rid="CR4">Carslaw and Jaeger (1959)</xref>.</p></sec><sec id="Sec6"><title>2.4. Derivation of the Inverse Gaussian density function</title><p>The IG function, as proposed by <xref ref-type="bibr" rid="CR22">Weiss (1996)</xref> utilises a statistical concept of absorption, where the probability of absorption changes with time. <xref ref-type="bibr" rid="CR23">Weiss et al. (1997)</xref> point at the relationship of the density function with the solution presented above (Eq. (<xref rid="Equ18" ref-type="">18</xref>)). In order to derive the IG function from Eq. (<xref rid="Equ18" ref-type="">18</xref>), we have to rewrite Eq. (<xref rid="Equ7" ref-type="">7</xref>). Using Eqs. (<xref rid="Equ13" ref-type="">13</xref>)&#8211;(<xref rid="Equ15" ref-type="">15</xref>), and (<xref rid="Equ18" ref-type="">18</xref>) we can rewrite Eq. (<xref rid="Equ7" ref-type="">7</xref>) as:
<disp-formula id="Equ20"><alternatives><tex-math id="M20">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$$N = {A_{\rm{D}}}{{{v^2}} \over D}\left( {{1 \over {2\sqrt \pi }}{{\left[ {{1 \over \tau }} \right]}^{3/2}}\zeta \exp \left( { - {{{{\left( {\zeta - \tau } \right)}^2}} \over {4\tau }}} \right)} \right)$$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu20.gif"/></alternatives></disp-formula> where the cross-sectional area, &#945;, cancels from the equation. If we look at unity transport distance, i.e. velocity expressed in terms of the mean distance between the site of administration and the site of absorption, <italic>vz</italic> &#8594; <italic>v</italic>, then:
<disp-formula id="Equ21"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$${N_{{\rm&lt;Subscript&gt;&lt;/Subscript&gt;}}} = {A_{\rm{D}}}{\left[ {{1 \over {4\pi {t^3}D}}} \right]^{1/2}}\exp \left( { - {{{{(1/v - t)}^2}} \over {4tD/{v^2}}}} \right)$$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu21.gif"/></alternatives></disp-formula>.</p><p>Now define the following two parameters:
<disp-formula id="Equ22"><alternatives><tex-math id="M22">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$${\rm{MAT}} = {1 \over v}$$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu22.gif"/></alternatives></disp-formula><disp-formula id="Equ23"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$${\rm{C}}{{\rm{V}}^{\rm{2}}} = {{2D} \over v}$$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu23.gif"/></alternatives></disp-formula> where MAT is the mean absorption time, and CV<sup>2</sup> the term expressing the variation in absorption time. Substitution in Eq. (<xref rid="Equ22" ref-type="">22</xref>) gives:
<disp-formula id="Equ24"><alternatives><tex-math id="M24">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$${N_{{\rm&lt;Subscript&gt;&lt;/Subscript&gt;}}} = {A_{\rm{D}}}{\left[ {{{{\rm{MAT}}} \over {2\pi {\rm{C}}{{\rm{V}}^2}t3}}} \right]^{1/2}}\exp \left( { - {{{{(t - {\rm{MAT}})}^2}} \over {2{\rm{C}}{{\rm{V}}^2}{\rm{MAT}}t}}} \right)$$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu24.gif"/></alternatives></disp-formula>. The above-derived equation is similar to the IG function and corresponds to Eq. (<xref rid="Equ3" ref-type="">3</xref>) in <xref ref-type="bibr" rid="CR22">Weiss (1996)</xref>. Further, mathematical properties of Eq. (<xref rid="Equ24" ref-type="">24</xref>) are discussed by <xref ref-type="bibr" rid="CR22">Weiss (1996)</xref>, <xref ref-type="bibr" rid="CR17">Ring (2001)</xref>, and <xref ref-type="bibr" rid="CR16">Ring et al. (2000)</xref>.</p></sec><sec id="Sec7"><title>2.5. Absorption percentiles</title><p>Using Eq. (<xref rid="Equ19" ref-type="">19</xref>), it is possible to calculate the time at which a certain fraction of drug has been absorbed. This can be achieved by iteratively solving Eq. (<xref rid="Equ19" ref-type="">19</xref>) for a desired value of <italic>M</italic> for repeated estimates of time. Bisection methods are generally efficient enough to obtain rapid convergence.</p></sec></sec><sec id="Sec8"><title>3. Example</title><p>To illustrate the use of the convection-dispersion equation for oral absorption, we applied the IG-input function (Eq. (<xref rid="Equ21" ref-type="">21</xref>)) to describe the absorption of paracetamol in a 22-year-old man (<xref ref-type="bibr" rid="CR13">Nimmo et al., 1973</xref>). Data were taken from literature by digital processing of Fig. <xref rid="Fig2" ref-type="fig">2</xref> in <xref ref-type="bibr" rid="CR13">Nimmo et al. (1973)</xref> using the WinDIG program (<xref ref-type="bibr" rid="CR12">Lovy, 1996</xref>). Dosage includes three consecutive single administrations of paracetamol (1500 mg) in the same individual, with enough washout in between administrations. This example covers a transport-related pharmacokinetic problem: paracetamol was administered alone, with metoclopramide, and with propantheline. Metaclopramide stimulates gastric emptying, while propantheline delays gastric emptying, thus influencing the mean-passage rate of the drug through the GI tract. This specific case therefore represents an example from literature where the feasibility of the transport-related absorption model can be verified. The model should be able to describe the concentration versus time curves, by using different transport velocities.
<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>Model fit for paracetamol absorption in a 22-year-old man using a 1-compartment model with first-order elimination and first-order absorption without lag time. Corresponding parameter estimates and &#8722;2LL value are provided in Table <xref rid="Tab1" ref-type="table">1</xref>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO2" position="float" orientation="portrait" xlink:href="11538_2006_Article_9122_Fig2.jpg"/></fig></p><p>The PK model that was used to describe the data is a 1-compartment massbalance model with first-order elimination:
<disp-formula id="Equ25"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$$\eqalign{ &amp; {N_{{\rm&lt;Subscript&gt;&lt;/Subscript&gt;}}} = {A_{\rm{D}}}{\left[ {{{{\rm{MAT}}} \over {2\pi {\rm{C}}{{\rm{V}}^2}t3}}} \right]^{1/2}}\exp ( - {{{{(t - {\rm{MAT}})}^2}} \over {2{\rm{C}}{{\rm{V}}^2}{\rm{MAT}}t}}) \cr &amp; {{{\rm{d}}A} \over {{\rm{d}}t}}i = {N_{{\rm{abs}}}}(t) - kA \cr} $$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu25.gif"/></alternatives></disp-formula>.</p><p>With the definition of plasma concentration and volumetric clearance as
<disp-formula id="Equ26"><alternatives><tex-math id="M26">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$$C = A/V$$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu26.gif"/></alternatives></disp-formula><disp-formula id="Equ27"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}
$${\rm{CL}} = kV$$
\end{document}</tex-math><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="anchor" orientation="portrait" xlink:href="11538_2006_Article_9122_TeX2GIFEqu27.gif"/></alternatives></disp-formula>.</p><p>Time series of plasma concentration after oral administration alone allows optimization of all the parameters in the absorption function, and of <italic>V</italic>/<italic>F</italic> and CL/<italic>F</italic>. The choice of a 1-compartment model was suggested by the fact that the concentration versus time data show only one exponential phase during washout.</p><p>The models&#8217; differential equation for the mass balance of the plasma compartment and the three different functions describing the absorption rate were implemented in NONMEM V, a computer program for optimisation of non-linear mixed effects models (<xref ref-type="bibr" rid="CR3">Boeckmann et al., 1994</xref>). This computer program estimates the model parameters by the maximum likelihood criterion. The model fits were compared using the minimum of &#8722;2&#215;log likelihood (&#8722;2LL).Model fits were diagnosed by plots of the residuals (the normalised difference between observed and predicted concentrations). A numerical solution method was selected for solving the differential equation and the absorption function simultaneously.</p><p>Absorption was described in four different ways: (1) Using a common first-order absorption function. This function contains one absorption parameter, <italic>K</italic><sub>a</sub>, which was allowed to vary between the three absorption cases (Eq. (<xref rid="Equ3" ref-type="">3</xref>)). (2) Using a first-order absorption function with a lag time. This function contains two absorption parameters, <italic>K</italic><sub>a</sub> and a lag time (<italic>t</italic><sub>lag</sub>). Only <italic>K</italic><sub>a</sub> was allowed to vary between the three absorption cases. (3) Absorption according to the IG function (Eqs. (<xref rid="Equ4" ref-type="">4</xref>) and (21)). This function also contains two absorption parameters, <italic>v</italic> and <italic>D</italic>. Only <italic>v</italic> was allowed to vary between the three absorption cases. (4) Similar to case 3, but with <italic>D</italic>/<italic>v</italic> optimised instead of <italic>D</italic>. Alternative models, with inter-occasion differences also identified on lag time or dispersion coefficient did not result in a satisfactory &#8722;2LL minimisation. Neither could the model with a constant <italic>K</italic><sub>a</sub> and <italic>t</italic><sub>lag</sub> varied between the three absorption cases converge to a successful minimisation.</p><p>Results of the above-described exercise are provided in Figs. <xref rid="Fig2" ref-type="fig">2</xref>&#8211;<xref rid="Fig6" ref-type="fig">6</xref> and Tables <xref rid="Tab1" ref-type="table">1</xref> and <xref rid="Tab2" ref-type="table">2</xref>. Figures <xref rid="Fig2" ref-type="fig">2</xref>&#8211;<xref rid="Fig5" ref-type="fig">5</xref> show the fits using the four different absorption models. All four models can describe differences in PK relating to the acceleration and delay of absorption when metoclopramide and propantheline are co-administrated. However, there are clear differences between the models for the fits of the concentration- time curves and the interpretation of the fitted parameters.
<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><p>Model fit for paracetamol absorption in a 22-year-old man using a 1-compartment model with first-order elimination and first-order absorption with lag time. Corresponding parameter estimates and &#8722;2LL value are provided in Table <xref rid="Tab1" ref-type="table">1</xref>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO3" position="float" orientation="portrait" xlink:href="11538_2006_Article_9122_Fig3.jpg"/></fig><fig id="Fig4" position="float" orientation="portrait"><label>Fig. 4</label><caption><p>Model fit for paracetamol absorption in a 22-year-old man using a 1-compartment model with first-order elimination and IG-input function with <italic>D</italic> optimised. Corresponding parameter estimates and &#8722;2LL value are provided in Table <xref rid="Tab1" ref-type="table">1</xref>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO4" position="float" orientation="portrait" xlink:href="11538_2006_Article_9122_Fig4.jpg"/></fig><fig id="Fig5" position="float" orientation="portrait"><label>Fig. 5</label><caption><p>Model fit for paracetamol absorption in a 22-year-old man using a 1-compartment model with first-order elimination and IG-input function with <italic>D</italic>/<italic>v</italic> optimised. Corresponding parameter estimates and &#8722;2LL value are provided in Table <xref rid="Tab1" ref-type="table">1</xref>.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO5" position="float" orientation="portrait" xlink:href="11538_2006_Article_9122_Fig5.jpg"/></fig><fig id="Fig6" position="float" orientation="portrait"><label>Fig. 6</label><caption><p>Residuals of the models fits for paracetamol absorption in a 22-year-old man using (1) 1-compartment model with first-order absorption (2) 1-compartment model with first-order absorption and an absorption lag time. (3) 1-compartment model with IG-absorption function (<italic>D</italic> optimised). (4) 1-compartment model with IG-absorption function (<italic>D</italic>/<italic>v</italic> optimised).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="MO6" position="float" orientation="portrait" xlink:href="11538_2006_Article_9122_Fig6.jpg"/></fig><table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Parameter estimates and likelihood (&#8722;2&#215;log likelihood) in the four different models for paracetamol absorption in a 22-year-old man.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1"/><th colspan="4" rowspan="1">Model</th></tr><tr><th colspan="1" rowspan="1"/><th colspan="2" rowspan="1">1st-order absorption</th><th colspan="2" rowspan="1">IG absorption</th></tr><tr><th colspan="1" rowspan="1">Characteristic</th><th colspan="1" rowspan="1">Without lag</th><th colspan="1" rowspan="1">With lag</th><th colspan="1" rowspan="1"><italic>D</italic> optimised</th><th colspan="1" rowspan="1">]<italic>D/v</italic> optimised</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">&#8722;2LL</td><td colspan="1" rowspan="1">59.3</td><td colspan="1" rowspan="1">29.2</td><td colspan="1" rowspan="1">25.5</td><td colspan="1" rowspan="1">19.6</td></tr><tr><td colspan="1" rowspan="1">Variance of residual error</td><td colspan="1" rowspan="1">3.3 (32)</td><td colspan="1" rowspan="1">1.1 (26)</td><td colspan="1" rowspan="1">0.95 (29)</td><td colspan="1" rowspan="1">0.76 (27)</td></tr><tr><td colspan="1" rowspan="1">No. of parameters</td><td colspan="1" rowspan="1">5</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">6</td><td colspan="1" rowspan="1">6</td></tr><tr><td colspan="1" rowspan="1">Absorption</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">K<sub>a</sub> (Normal)</td><td colspan="1" rowspan="1">0.58 (16)</td><td colspan="1" rowspan="1">1.1 (17)</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td></tr><tr><td colspan="1" rowspan="1">K<sub>a</sub> (Accelerated)</td><td colspan="1" rowspan="1">0.98 (20)</td><td colspan="1" rowspan="1">2.4 (25)</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td></tr><tr><td colspan="1" rowspan="1">K<sub>a</sub> (Delayed)</td><td colspan="1" rowspan="1">0.17 (22)</td><td colspan="1" rowspan="1">0.26 (18)</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td></tr><tr><td colspan="1" rowspan="1"><italic>t</italic><sub>lag</sub></td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">0.30 (15)</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td></tr><tr><td colspan="1" rowspan="1"><italic>D</italic></td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">0.17 (20)</td><td colspan="1" rowspan="1">&#8211;</td></tr><tr><td colspan="1" rowspan="1"><italic>D/v</italic></td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">0.32 (47)</td></tr><tr><td colspan="1" rowspan="1"><italic>v</italic>(Normal)</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">0.91 (9.3)</td><td colspan="1" rowspan="1">]0.62 (34)</td></tr><tr><td colspan="1" rowspan="1"><italic>v</italic> (Accelerated)</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">1.6 (17)</td><td colspan="1" rowspan="1">0.98 (40)</td></tr><tr><td colspan="1" rowspan="1"><italic>v</italic> (Delayed)</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">&#8211;</td><td colspan="1" rowspan="1">0.22 (27)</td><td colspan="1" rowspan="1">0.27 (32)</td></tr><tr><td colspan="1" rowspan="1">Disposition</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1"><italic>CL/F</italic></td><td colspan="1" rowspan="1">33 (6.8)</td><td colspan="1" rowspan="1">37 (4.5)</td><td colspan="1" rowspan="1">37 (5.4)</td><td colspan="1" rowspan="1">41 (4.3)</td></tr><tr><td colspan="1" rowspan="1"><italic>V/F</italic></td><td colspan="1" rowspan="1">61 (6.2)</td><td colspan="1" rowspan="1">74 (6.3)</td><td colspan="1" rowspan="1">80 (7.1)</td><td colspan="1" rowspan="1">52 (35)</td></tr></tbody></table><table-wrap-foot><p><italic>Note</italic>. Values in parentheses refer to the coefficient of variation, (the standard error of the estimate divided by the estimate &#215;100%).</p></table-wrap-foot></table-wrap></p><p>The first-order model (Fig. <xref rid="Fig2" ref-type="fig">2</xref>) shows a strong mismatch between the model predictions and the observations. The model cannot describe the maximum concentration, while the concentration upswing is overestimated. This also becomes clear in the plot of the residuals against time (Fig. <xref rid="Fig6" ref-type="fig">6</xref>, panel 1): The residuals are not evenly distributed along the origin. If a lag time is added to the first-order absorption model (Fig. <xref rid="Fig3" ref-type="fig">3</xref>) the model fit improves. Closer inspection of the residuals against time (Fig. <xref rid="Fig6" ref-type="fig">6</xref>, panel 2) however, indicates that some bias remains.</p><p>The fit of the models that employ the IG function are displayed in Figs. <xref rid="Fig4" ref-type="fig">4</xref> and <xref rid="Fig5" ref-type="fig">5</xref>. Both models describe the data better than the first-order models. Remarkably, the fit where bias in the residuals is absent is when <italic>D</italic>/<italic>v</italic> is optimised and not <italic>D</italic> (Compare Fig. <xref rid="Fig6" ref-type="fig">6</xref>, panel 3 and 4). Optimisation of the dispersion coefficient scaled to the velocity suggests an increase of the dispersion coefficient with velocity. This correlation has also been observed in other disciplines that study transport processes, such as hydrology (<xref ref-type="bibr" rid="CR2">Biggar and Nielsen, 1976</xref>), and indicates that variability in the transport velocity increases with velocity. This approach is in accordance with the reparameterisation that is used in the derivation of the IG function from the solution of the convection-dispersion equation (Eqs. (<xref rid="Equ22" ref-type="">22</xref>)&#8211;(<xref rid="Equ24" ref-type="">24</xref>)), and its original presentation as a statistical absorption function (<xref ref-type="bibr" rid="CR22">Weiss, 1996</xref>).</p><p>Parametric results of the model fits are provided in Table <xref rid="Tab1" ref-type="table">1</xref>. A comparison of the likelihood values and the residual error between the different models confirms that the IG function is superior to the first-order absorption models in describing the data (Table <xref rid="Tab1" ref-type="table">1</xref>). The estimated clearance and distribution volumes are comparable for the various models. This suggests that the type of absorption model has no major impact on the estimates of the disposition parameters. The estimated absorption parameters all reflect the influence of co-administration of metoclopramide and propantheline, but quite differently. The first-order model explains the influence by different estimates of the absorption parameter, <italic>K</italic><sub>a</sub>, which would suggest that metoclopramide and propantheline influence the actual uptake rate from the gut compartment. Identification of a variable lag time to explain the effect of these drugs was not successful for the first-order model. The transport-limited absorption model explains the influence of metoclopramide and propantheline through the transport velocity, which corresponds to the expected effect of these drugs on gastric emptying.</p><p>The uncertainty of the parameter estimates is low (coefficient of variation mostly less than 25%). For the model that fits the data best (IG absorption with <italic>D</italic>/<italic>v</italic> optimised) the coefficients of variation of all parameters, except CL/<italic>F</italic> are somewhat higher than for the other models (about 40%). This is accompanied by a strong correlation between these estimates (&gt;0.95) that was not found for the other models. This is presumably caused by the scaling of the dispersion coefficient <italic>D</italic> to the transport velocity, <italic>v</italic>. While providing a better simultaneous description of the three PK curves, scaling results in an intrinsic correlation between the parameters.</p><p>The differences in the estimated absorption parameters (Table <xref rid="Tab1" ref-type="table">1</xref>) have a distinct effect on the derived cumulative absorption profiles. Table <xref rid="Tab2" ref-type="table">2</xref> shows the times of the absorption percentiles for the four different models. There is a considerable difference in the computed moments in time at which a certain fraction was absorbed. In general, the first-order model without lag time shows a very early onset of the absorption, which is in correspondence with the observation that the model overestimates the concentrations before the maximum concentration is reached (Fig. <xref rid="Fig2" ref-type="fig">2</xref>). Additionally, for this model the 90 absorption percentile occurs much later than for the other three models: for the delayed absorption it occurs at an unrealistically long time of 13 h. The absorption percentile times of the first-order model with lag time and the two IG-absorption models correspond quite good for the upswing. However, for the first-order model with lag time, there is the limitation of the sudden start of absorption at the lag time (0.3 h), whereas for the IG-absorption model, cumulative absorption rises continuously from the time of administration, therefore providing a much more realistic estimate for the lower-absorption percentiles. The IG-absorption model with <italic>D</italic>/<italic>v</italic> optimised is the only model that predicts a relatively short absorption tail for the delayed absorption case (90 percentile at 7.3 h).
<table-wrap id="Tab2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Derived absorption percentiles, following four different models for paracetamol absorption in a 22-year-old man.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1"/><th colspan="4" rowspan="1">Time after administration (h)</th></tr><tr><th colspan="1" rowspan="1"/><th colspan="2" rowspan="1">1st-order absorption</th><th colspan="2" rowspan="1">IG absorption</th></tr><tr><th colspan="1" rowspan="1">% Absorbed</th><th colspan="1" rowspan="1">Without lag</th><th colspan="1" rowspan="1">With lag</th><th colspan="1" rowspan="1"><italic>D</italic> optimised</th><th colspan="1" rowspan="1"><italic>D/v</italic> optimised</th></tr></thead><tbody><tr><td colspan="1" rowspan="1">Normal absorption</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0.18</td><td colspan="1" rowspan="1">0.40</td><td colspan="1" rowspan="1">0.45</td><td colspan="1" rowspan="1">0.50</td></tr><tr><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0.38</td><td colspan="1" rowspan="1">0.50</td><td colspan="1" rowspan="1">0.57</td><td colspan="1" rowspan="1">0.68</td></tr><tr><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">1.2</td><td colspan="1" rowspan="1">0.93</td><td colspan="1" rowspan="1">0.93</td><td colspan="1" rowspan="1">1.2</td></tr><tr><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">2.8</td><td colspan="1" rowspan="1">1.8</td><td colspan="1" rowspan="1">1.5</td><td colspan="1" rowspan="1">2.3</td></tr><tr><td colspan="1" rowspan="1">90</td><td colspan="1" rowspan="1">4.0</td><td colspan="1" rowspan="1">2.4</td><td colspan="1" rowspan="1">2.0</td><td colspan="1" rowspan="1">3.2</td></tr><tr><td colspan="1" rowspan="1">Accelerated</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0.11</td><td colspan="1" rowspan="1">0.34</td><td colspan="1" rowspan="1">0.32</td><td colspan="1" rowspan="1">0.32</td></tr><tr><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0.23</td><td colspan="1" rowspan="1">0.39</td><td colspan="1" rowspan="1">0.40</td><td colspan="1" rowspan="1">0.43</td></tr><tr><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">0.71</td><td colspan="1" rowspan="1">0.59</td><td colspan="1" rowspan="1">0.57</td><td colspan="1" rowspan="1">0.78</td></tr><tr><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">1.6</td><td colspan="1" rowspan="1">0.97</td><td colspan="1" rowspan="1">0.83</td><td colspan="1" rowspan="1">1.5</td></tr><tr><td colspan="1" rowspan="1">90</td><td colspan="1" rowspan="1">2.4</td><td colspan="1" rowspan="1">1.3</td><td colspan="1" rowspan="1">1.0</td><td colspan="1" rowspan="1">2.0</td></tr><tr><td colspan="1" rowspan="1">Delayed</td><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/><td colspan="1" rowspan="1"/></tr><tr><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">0.62</td><td colspan="1" rowspan="1">0.71</td><td colspan="1" rowspan="1">0.80</td><td colspan="1" rowspan="1">1.2</td></tr><tr><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">1.3</td><td colspan="1" rowspan="1">1.2</td><td colspan="1" rowspan="1">1.2</td><td colspan="1" rowspan="1">1.6</td></tr><tr><td colspan="1" rowspan="1">50</td><td colspan="1" rowspan="1">4.1</td><td colspan="1" rowspan="1">3.0</td><td colspan="1" rowspan="1">2.6</td><td colspan="1" rowspan="1">2.8</td></tr><tr><td colspan="1" rowspan="1">80</td><td colspan="1" rowspan="1">9.5</td><td colspan="1" rowspan="1">6.5</td><td colspan="1" rowspan="1">6.5</td><td colspan="1" rowspan="1">5.3</td></tr><tr><td colspan="1" rowspan="1">90</td><td colspan="1" rowspan="1">13</td><td colspan="1" rowspan="1">9.1</td><td colspan="1" rowspan="1">10</td><td colspan="1" rowspan="1">7.3</td></tr></tbody></table></table-wrap></p></sec><sec id="Sec9"><title>4. Discussion and conclusions</title><p>There has been considerable debate on the derivation of the IG function from the underlying partial differential equation, the convection-dispersion equation (<xref ref-type="bibr" rid="CR9">Hisaka and Sugiyama, 1999</xref>; <xref ref-type="bibr" rid="CR18">Roberts et al., 2000</xref>). <xref ref-type="bibr" rid="CR9">Hisaka and Sugiyama (1999)</xref> have pointed out the importance of the proper initial and boundary conditions. A concentration upper-boundary condition is incorrect, since it cannot adequately control the mass-exchange at the boundary. Instead, the proper upper-boundary condition should preserve continuity of mass. The lower-boundary condition relates to the local conditions at the receiving site. The total mass balance that is commonly used at the absorption site in PK models is, however, not very informative for specifying this lower-boundary condition. The commonly used IG function relates to the solution of the flux-averaged concentration with an instantaneous injection as the upper-boundary condition and the lower-boundary condition specified in Eq. (<xref rid="Equ11" ref-type="">11</xref>). The upper-boundary condition therefore preserves continuity of mass (<xref ref-type="bibr" rid="CR23">Weiss et al., 1997</xref>). The lower-boundary condition that relates to the IG function assumes that the resident concentration gradient is zero at infinite distance.</p><p>The application of the IG function to the paracetamol data show that the IG function can adequately describe the upswing of the concentration versus time curve. This confirms results obtained in earlier studies (<xref ref-type="bibr" rid="CR22">Weiss, 1996</xref>; <xref ref-type="bibr" rid="CR23">Weiss et al., 1997</xref>). The function is particularly interesting when abundant data is available before the occurrence of the inflection point in the measurements. In such cases the use of the first-order model frequently yields a mismatch between the model-fit and the observations. In drug development, the property of the IG-input function to describe an inflection point may be of crucial importance when quantifying and comparing moments of absorbed amount of drug derived from the concentration data. When deriving the absorption rate from concentration data, using the first-order model, the bias of the model fit inevitably propagates to the calculated fraction of absorption. This is particularly important for the development of drugs where the time of the intended effect is crucial, such as for analgesics, sleepinducing drugs and drugs used in the management of migraine attacks. In these cases one of the aims may be to optimise the onset of the effect by controlling the oral absorption rate. An accurate assessment of the absorption rate is then required to compare clinical trial results of new drugs with existing reference drugs.</p><p>Several alternative approaches for describing the absorption rate have been proposed (<xref ref-type="bibr" rid="CR15">Piotrovskii, 1987</xref>; <xref ref-type="bibr" rid="CR20">Tatsunami et al., 1998</xref>; <xref ref-type="bibr" rid="CR8">Higaki et al., 2001</xref>; <xref ref-type="bibr" rid="CR1">Lansky and Weiss, 2003</xref>; <xref ref-type="bibr" rid="CR24">Zhou, 2003</xref>). In comparison with the other approaches, the IG function is of interest when transport through the GI tract limits the absorption rate. We have shown that the influence of metoclopramide and propantheline on paracetamol absorption could be modelled with the IG function by varying the transport velocity. This directly reflects the effect of metoclopramide and propantheline on gastric emptying. The convection-dispersion equation that forms the basis for the IG function has many other solutions for different types of boundary conditions and coordinate systems (<xref ref-type="bibr" rid="CR4">Carslaw and Jaeger, 1959</xref>; <xref ref-type="bibr" rid="CR5">Crank, 1975</xref>) that may be of future use in pharmacokinetic research.</p></sec></body><back><ref-list id="Bib1"><title>References</title><ref id="CR1"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Abramovitz</surname><given-names>M.</given-names></name><name name-style="western"><surname>Stegun</surname><given-names>I.A.</given-names></name></person-group><source>Handbook of mathematical functions. In: Applied Mathematics Series 55</source><year>1966</year><publisher-loc>Washington, DC.</publisher-loc><publisher-name>National Bureau of Standards</publisher-name></mixed-citation></ref><ref id="CR2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Biggar</surname><given-names>J.W.</given-names></name><name name-style="western"><surname>Nielsen</surname><given-names>D.R.</given-names></name></person-group><article-title>Spatial variability of the leaching characteristics of a field soil</article-title><source>Water Resour. Res.</source><year>1976</year><volume>12</volume><fpage>78</fpage><lpage>84</lpage><pub-id pub-id-type="doi">10.1029/WR012i001p00078</pub-id></mixed-citation></ref><ref id="CR3"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Boeckmann</surname><given-names>A.J.</given-names></name><name name-style="western"><surname>Sheiner</surname><given-names>L.B.</given-names></name><name name-style="western"><surname>Beal</surname><given-names>S.L.</given-names></name></person-group><source>NONMEM Users Guide&#8212;Part V</source><year>1994</year><publisher-loc>San Francisco</publisher-loc><publisher-name>NONMEM Project Group</publisher-name></mixed-citation></ref><ref id="CR4"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Carslaw</surname><given-names>H.S.</given-names></name><name name-style="western"><surname>Jaeger</surname><given-names>J.C.</given-names></name></person-group><source>Conduction of Heat in Solids, 2nd edition</source><year>1959</year><publisher-loc>Oxford, UK</publisher-loc><publisher-name>Oxford University Press</publisher-name></mixed-citation></ref><ref id="CR5"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Crank</surname><given-names>J.</given-names></name></person-group><source>The Mathematics of Diffusion, 2nd edition</source><year>1975</year><publisher-loc>Oxford, UK</publisher-loc><publisher-name>Oxford University Press</publisher-name></mixed-citation></ref><ref id="CR6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Freijer</surname><given-names>J.I.</given-names></name><name name-style="western"><surname>Veling</surname><given-names>E.J.M.</given-names></name><name name-style="western"><surname>Hassanizadeh</surname><given-names>S.M.</given-names></name></person-group><article-title>Analytical solutions of the convection-dispersion equation applied to transport of pesticides in soil columns</article-title><source>Environ. Model. Softw.</source><year>1998</year><volume>13</volume><fpage>139</fpage><lpage>149</lpage><pub-id pub-id-type="doi">10.1016/S1364-8152(98)00016-4</pub-id></mixed-citation></ref><ref id="CR7"><mixed-citation publication-type="other">Gabrielson, J., Weiner, D., 2000. Pharmacokinetic and Pharmacodynamic Data Analysis. Concepts and Applications, 3rd edition Apotekarsocieteten, Stockholm, Sweden.</mixed-citation></ref><ref id="CR8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Higaki</surname><given-names>K.</given-names></name><name name-style="western"><surname>Yamashita</surname><given-names>S.</given-names></name><name name-style="western"><surname>Amidon</surname><given-names>G.K.</given-names></name></person-group><article-title>Time-dependent oral absorption models</article-title><source>J. Pharmacokinet. Pharmacodynam.</source><year>2001</year><volume>28</volume><fpage>109</fpage><lpage>128</lpage><pub-id pub-id-type="doi">10.1023/A:1011573831444</pub-id><pub-id pub-id-type="pmid">11381566</pub-id></mixed-citation></ref><ref id="CR9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hisaka</surname><given-names>A.</given-names></name><name name-style="western"><surname>Sugiyama</surname><given-names>Y.</given-names></name></person-group><article-title>Notes on the inverse Gaussian distribution and choice of boundary conditions for the dispersion model in the analysis of local pharmacokinetics</article-title><source>J. Pharm. Sci.</source><year>1999</year><volume>88</volume><fpage>1362</fpage><lpage>1365</lpage><pub-id pub-id-type="doi">10.1021/js9803860</pub-id><pub-id pub-id-type="pmid">10585235</pub-id></mixed-citation></ref><ref id="CR10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kreft</surname><given-names>A.</given-names></name><name name-style="western"><surname>Zuber</surname><given-names>A.</given-names></name></person-group><article-title>On the physical meaning of the dispersion equation and its solutions for different initial and boundary conditions</article-title><source>Chem. Eng. Sci.</source><year>1978</year><volume>33</volume><fpage>1471</fpage><lpage>1480</lpage><pub-id pub-id-type="doi">10.1016/0009-2509(78)85196-3</pub-id></mixed-citation></ref><ref id="CR11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lansky</surname><given-names>P.</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>M.</given-names></name></person-group><article-title>Classification of dissolution profiles in terms of fractional dissolution rate and a novel measure of heterogeneity</article-title><source>J. Pharm. Sci.</source><year>2003</year><volume>92</volume><fpage>1632</fpage><lpage>1647</lpage><pub-id pub-id-type="doi">10.1002/jps.10419</pub-id><pub-id pub-id-type="pmid">12884250</pub-id></mixed-citation></ref><ref id="CR12"><mixed-citation publication-type="other">Lovy, D., 1996. WinDIG v2.5 Free Data Digitizer.</mixed-citation></ref><ref id="CR13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Nimmo</surname><given-names>J.</given-names></name><name name-style="western"><surname>Heading</surname><given-names>R.C.</given-names></name><name name-style="western"><surname>Tothill</surname><given-names>P.</given-names></name><name name-style="western"><surname>Prescott</surname><given-names>L.F.</given-names></name></person-group><article-title>Pharmacological modification of gastric emptying: Effects of Propantheline and Metoclopromide on paracetamol absorption</article-title><source>Br. Med. J.</source><year>1973</year><volume>1</volume><fpage>587</fpage><lpage>589</lpage><pub-id pub-id-type="doi">10.1136/bmj.1.5853.587</pub-id><pub-id pub-id-type="pmid">4694406</pub-id><pub-id pub-id-type="pmcid">PMC1589913</pub-id></mixed-citation></ref><ref id="CR14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Parlange</surname><given-names>J.-Y</given-names></name><name name-style="western"><surname>Starr</surname><given-names>J.L.</given-names></name><name name-style="western"><surname>Genuchten</surname><given-names>M.Th.</given-names></name><name name-style="western"><surname>Barry</surname><given-names>D.A.</given-names></name><name name-style="western"><surname>Parker</surname><given-names>J.C.</given-names></name></person-group><article-title>Exit condition for miscible displacement experiments</article-title><source>Soil Sci.</source><year>1992</year><volume>153</volume><fpage>165</fpage><lpage>171</lpage><pub-id pub-id-type="doi">10.1097/00010694-199203000-00001</pub-id></mixed-citation></ref><ref id="CR15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Piotrovskii</surname><given-names>V.K.</given-names></name></person-group><article-title>The use of Weibull distribution to describe the in vivo absorption kinetics</article-title><source>J. Pharmacokinet. Biopharm.</source><year>1987</year><volume>15</volume><fpage>681</fpage><lpage>686</lpage><pub-id pub-id-type="doi">10.1007/BF01068420</pub-id><pub-id pub-id-type="pmid">3450849</pub-id></mixed-citation></ref><ref id="CR16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ring</surname><given-names>A.</given-names></name><name name-style="western"><surname>Tothfalusi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Endenyi</surname><given-names>L.</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>M.</given-names></name></person-group><article-title>Sensitivity of empirical metrics of rate of absorption in bioequivalence studies</article-title><source>Pharm. Res.</source><year>2000</year><volume>17</volume><fpage>583</fpage><lpage>588</lpage><pub-id pub-id-type="doi">10.1023/A:1007521016985</pub-id><pub-id pub-id-type="pmid">10888310</pub-id></mixed-citation></ref><ref id="CR17"><mixed-citation publication-type="other">Ring, A., 2001. Einfluss der Modellwahl auf die Zuverl&#225;ssigkeit der Sch&#225;tzung pharmakokinetischer Parameter. Dissertation. Halle-Wittenberg.</mixed-citation></ref><ref id="CR18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Roberts</surname><given-names>M.S.</given-names></name><name name-style="western"><surname>Anissimov</surname><given-names>Y.G.</given-names></name><name name-style="western"><surname>Weiss</surname><given-names>M.</given-names></name></person-group><article-title>Commentary: Using the convection-dispersion model transit time functions in the analysis of organ distribution kinetics</article-title><source>J. Pharm. Sci.</source><year>2000</year><volume>89</volume><fpage>1579</fpage><lpage>1586</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/1520-6017(200012)89:12&amp;#x0003c;1579::AID-JPS8&amp;#x0003e;3.0.CO;2-Y</pub-id><pub-id pub-id-type="pmid">11042605</pub-id></mixed-citation></ref><ref id="CR19"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Shargel</surname><given-names>L.</given-names></name><name name-style="western"><surname>Yu</surname><given-names>A.</given-names></name></person-group><source>Applied Biopharmacokinetics, 4th edition</source><year>1999</year><publisher-loc>CT</publisher-loc><publisher-name>Appleton and Lange</publisher-name></mixed-citation></ref><ref id="CR20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tatsunami</surname><given-names>S.</given-names></name><name name-style="western"><surname>Sako</surname><given-names>K.</given-names></name><name name-style="western"><surname>Kuwabara</surname><given-names>R.</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>K.</given-names></name></person-group><article-title>Using Gaussian-like input rate function in the two-compartment model. Formulation and application to analysis of Didanosine plasma concentration in two Japanese hemophiliacs</article-title><source>Int. J. Clin. Pharm. Res.</source><year>1998</year><volume>18</volume><fpage>129</fpage><lpage>13</lpage><pub-id pub-id-type="pmid">9825269</pub-id></mixed-citation></ref><ref id="CR21"><mixed-citation publication-type="book"><person-group person-group-type="author"><name name-style="western"><surname>Veling</surname><given-names>E.J.M.</given-names></name></person-group><source>ZEROCD and PROFCD. Description of two programs to supply quick information with respect to the penetration of tracers into the soil</source><year>1993</year><publisher-loc>Bilthoven, The Netherlands</publisher-loc><publisher-name>National Institute of Public Health and the Environment</publisher-name></mixed-citation></ref><ref id="CR22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weiss</surname><given-names>M.</given-names></name></person-group><article-title>A novel extravascular input function for the assessment of drug absorption in bioavailability studies</article-title><source>Pharm. Res.</source><year>1996</year><volume>13</volume><fpage>1547</fpage><lpage>1553</lpage><pub-id pub-id-type="doi">10.1023/A:1016039931663</pub-id><pub-id pub-id-type="pmid">8899849</pub-id></mixed-citation></ref><ref id="CR23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Weiss</surname><given-names>M.</given-names></name><name name-style="western"><surname>Stedtler</surname><given-names>C.</given-names></name><name name-style="western"><surname>Roberts</surname><given-names>M.S.</given-names></name></person-group><article-title>On the validity of the dispersion model of hepatic drug elimination when intravascular transit time densities are long-tailed</article-title><source>Bull. Math. Biol.</source><year>1997</year><volume>59</volume><fpage>991</fpage><lpage>992</lpage><pub-id pub-id-type="doi">10.1007/BF02459999</pub-id><pub-id pub-id-type="pmid">9281905</pub-id></mixed-citation></ref><ref id="CR24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>H.</given-names></name></person-group><article-title>Pharmacokinetic strategies in deciphering atypical drug absorption profiles</article-title><source>J. Clin. Pharmacol.</source><year>2003</year><volume>43</volume><fpage>211</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1177/0091270002250613</pub-id><pub-id pub-id-type="pmid">12638389</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>